Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Thursday, August 8, 2024

Endometrial cancer patients see new hope as FDA approves 'transforming' immunotherapy drug

 August 08, 2024     Health, Health News Today on Fox News     No comments   

The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer.

Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK — is intended for people with primary advanced or recurrent forms of the cancer, according to the FDA’s Aug. 1 announcement.

It is an immunotherapy-based drug, which means it leverages the body’s immune system to attack cancer cells.

SOME TAMPON PRODUCTS FOUND TO CONTAIN TOXIC METALS IN FIRST-TIME STUDY: 'HARMFUL INGREDIENTS'

In clinical trials, Jemperli showed an improved progression-free survival and overall survival for all patients, according to Dr. Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Florida.

"This class of drugs has been used in the second-line setting," Slomovitz said — meaning they were only used if a first-line (primary) treatment was not effective or had intolerable side effects.

"Moving them to first-line [status] here will yield better outcomes."

This is the third FDA approval this year for immunotherapy in endometrial cancer, the doctor noted.

THE 9 MOST COMMON QUESTIONS WOMEN OVER 40 ASK THEIR DOCTORS, ACCORDING TO A MENOPAUSE EXPERT

"This is great news for our patients," Slomovitz told Fox News Digital.

"Endometrial cancer has become the leading cause of death over all other gynecologic cancers, including ovarian cancer."

Before the immunotherapy options became available, the only treatment for endometrial cancer was chemotherapy alone, Slomovitz said. 

"These results are game-changing — it is unprecedented to have three approvals in such a short period of time."

The most common side effects of all immunotherapy drugs are gastrointestinal, endocrine and dermatologic toxicities, the doctor noted.

"Patients should understand that adding immunotherapy to traditional chemotherapy has better results and the toxicity profile is manageable," he added.

For doctors, Slomovitz emphasized the need to adjust quickly and make the newly approved drug a first-line treatment option for their patients.

In June, the FDA approved Merck’s Keytruda (pembrolizumab) to be used in combination with chemotherapy for adult patients with primary advanced or recurrent endometrial cancer.

"The Merck trial (pembrolizumab) showed a significant improvement in progression-free survival for all patients," Slomovitz said.

In that same month, AstraZeneca’s Imfinzi (durvalumab) was approved for patients with advanced or recurrent disease who have a certain biomarker.

The AstraZeneca trial also showed improved progression-free survival for all patients. 

All trials for the new cancer drugs were run through the GOG Foundation, which is the largest cooperative group for all gynecologic oncology research, Slomovitz noted. 

In the trials, the use of immunotherapy drugs in combination with chemotherapy reduced the risk of disease progression by approximately 70% in patients whose tumors had certain biomarkers.

In other patients without that biomarker, there was still a "clinically and statistically significant improvement in time to progression, which is meaningful for our patients and has now led to FDA approvals in both biomarker settings," Kathleen N. Moore, M.D., co-director of the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"These studies have transformed outcomes for patients with endometrial cancer and are poised to change the treatment landscape for the better into the future," she added.

Shannon N. Westin, medical director of the Gynecologic Oncology Center at the University of Texas MD Anderson Cancer Center, said she is "thrilled" to have multiple new options for patients with advanced and recurrent endometrial cancer after years with no new therapies.

"We no longer have to treat everyone in the same cookie-cutter fashion, and can instead employ precision medicine to improve survival for these survivors."

For more Health articles, visit www.foxnews/health

"The addition of immunotherapy to chemotherapy provided improvement in survival outcomes without a negative impact on quality of life," she went on. 

"This is the ideal scenario."

Fox News Digital reached out to GSK for comment.



from Health News Today on Fox News https://ift.tt/NfF5Re8
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • Oregon mom warns about 'vicious' polio-like illness that left daughter a quadriplegicIt’s been almost four years since McKenzie Andersen’s life flipped upside down. from FOX News https://ift.tt/2NXcsxy … Read More
  • 'Polio-like' illness cases investigated by CDC: Should you be concerned?Read on for a look at the illness and what you should know about it. from FOX News https://ift.tt/2yVSsWH … Read More
  • FOX NEWS: Oregon mom warns about 'vicious' polio-like illness that left daughter a quadriplegic Oregon mom warns about 'vicious' polio-like illness that left daughter a quadriplegic It’s been almost four years since McKenzie Andersen’s life f… Read More
  • FOX NEWS: Viral outbreak at New Jersey pediatric center kills 6 kids Viral outbreak at New Jersey pediatric center kills 6 kids Health officials confirmed the presence of adenovirus 7 at the Wanaque Center for Nursi… Read More
  • FOX NEWS: 'Polio-like' illness cases investigated by CDC: Should you be concerned? 'Polio-like' illness cases investigated by CDC: Should you be concerned? Read on for a look at the illness and what you should know about it. via… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD

Recent Posts

Categories

  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • May 2025 (41)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates